Medical Advancement & Innovation - The Neurology field significantly reduced patients' 90-day recurrence rate from 11.7% to 8.2% in the "CHANCE" clinical trial [1] - Subsequent studies further decreased the recurrence rate to 6% [1] - Domestically produced thrombolytic drugs were developed, ending reliance on expensive imports [1] - AI imaging systems were combined with thrombolytic drugs to cut treatment times from 120 minutes to 20 minutes [1] - The treatment window was extended from 4.5 hours to 24 hours [1] Impact & Leadership - The research rewrote global treatment guidelines, saving millions of lives [1] - The work exemplifies the courage to leave the comfort zone and transform an entire field [1]